Pharma sector has become more popular for mergers and acquisitions (M&A) in China. In 2018, the drug sector accounted for 63 percent of the total transaction value of the M&A activities in the Chinese life science industry.
Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- VC and PE investment in China healthcare 2012-H1 2020
- Healthcare deals quarterly value U.S. 2019-2020, by industry
- Healthcare deals quarterly number U.S. 2019-2020, by industry
- Number of healthcare deals quarterly U.S. 2017-2020
- Healthcare deals quarterly U.S. 2017-2020, by value
- Partnership deal value in China's healthcare industry 2012-H1 2020
- Value of mergers and acquisitions (M&A) deals in China healthcare 2012-H1 2020
- China's healthcare IPO fund value 2012-H1 2020
- Foreign deals of M&A investment in China's life science industry 2018, by acquirer
- Domestic deals of M&A investment in China's life science industry 2018, by acquirer
- Key figures of life science investment in China 2008-2020
- Life science investment estimated growth rate in China 2020, by type
- 2011 - U.S. government healthcare coverage by age group
- Place of death by ethnicity
- Gross output of total health care and social assistance 1998-2019
- Grades on selected U.S. health care system dimensions in 2011
- View of military veteran health research funded by government - U.S. adults 2015
- Ambulatory health care establishments U.S. total number 2007-2017
ChinaBio. (January 6, 2019). Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector [Graph]. In Statista. Retrieved March 07, 2021, from https://www.statista.com/statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/
ChinaBio. "Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector ." Chart. January 6, 2019. Statista. Accessed March 07, 2021. https://www.statista.com/statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/
ChinaBio. (2019). Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector . Statista. Statista Inc.. Accessed: March 07, 2021. https://www.statista.com/statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/
ChinaBio. "Share of The Merger and Acquisition Deal Value in The Life Science Industry in China in 2018, by Sector ." Statista, Statista Inc., 6 Jan 2019, https://www.statista.com/statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/
ChinaBio, Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector Statista, https://www.statista.com/statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/ (last visited March 07, 2021)